Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.9%

1 terminated out of 54 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

33%

5 of 15 completed with results

Key Signals

5 with results94% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (12)
P 1 (4)
P 2 (6)
P 3 (4)
P 4 (4)

Trial Status

Recruiting21
Completed15
Not Yet Recruiting10
Enrolling By Invitation5
Unknown1
Active Not Recruiting1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT06678841Not ApplicableRecruitingPrimary

ELEVATE-HFpEF Clinical Study

NCT07565610Not Yet Recruiting

Changes in Intramyocardial Fat Assessed by Cardiac CT Before and After Bariatric Surgery and Their Relationship With Cardiac Diastolic Function

NCT07560436Phase 2RecruitingPrimary

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

NCT06768437RecruitingPrimary

The Role of Epicardial Adiposity in Heart Failure With Preserved Ejection Fraction

NCT07529860Not ApplicableNot Yet Recruiting

AI-based Echocardiography for Detection of Cardiac Amyloidosis

NCT07521293CompletedPrimary

Intracranial Pressure and a Potential Vicious Circle of Atrial Fibrillation in HFpEF

NCT07219511Phase 1Recruiting

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

NCT07324772Not ApplicableNot Yet Recruiting

PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

NCT07185100RecruitingPrimary

Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR

NCT07295522Phase 4Not Yet Recruiting

Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

NCT06930495Enrolling By InvitationPrimary

The Effect of Adiposity on Muscle and Microvascular Function in HFpEF

NCT07022379Completed

Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program

NCT07493590Not Yet RecruitingPrimary

CAPTURE-HFpEF: National Study of Identification and Phenotyping of Heart Failure With Preserved Ejection Fraction

NCT06905405RecruitingPrimary

The Use of Advanced Imaging in HFpEF

NCT04592445Not ApplicableRecruitingPrimary

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

NCT06909682Recruiting

AI-Based Monitoring System for Chronic Heart Failure With Advanced Wearable and Mini-Invasive Devices

NCT05371496Phase 2Enrolling By Invitation

Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction

NCT07429396Not Yet Recruiting

Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction

NCT07417215Phase 4Not Yet RecruitingPrimary

The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

NCT07272902Not ApplicableRecruiting

Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication

Scroll to load more

Research Network

Activity Timeline